Literature DB >> 11284032

Molecular analysis of a familial case of renal cell cancer and a t(3;6)(q12;q15).

M J Eleveld1, D Bodmer, G Merkx, A Siepman, S H Sprenger, M A Weterman, M J Ligtenberg, J Kamp, W Stapper, J W Jeuken, D Smeets, A Smits, A Geurts Van Kessel.   

Abstract

We identified a novel familial case of clear-cell renal cancer and a t(3;6)(q12;q15). Subsequent cytogenetic and molecular analyses showed the presence of several abnormalities within tumour samples obtained from different patients. Loss of the der(3) chromosome was noted in some, but not all, of the samples. A concomitant VHL gene mutation was found in one of the samples. In addition, cytogenetic and molecular evidence for heterogeneity was obtained through analysis of several biopsy samples from one of the tumours. Based on these results and those reported in the literature, we conclude that loss of der(3) and subsequent VHL gene mutation may represent critical steps in the development of renal cell cancers in persons carrying the chromosome 3 translocation. Moreover, preliminary data suggest that other (epi)genetic changes may be related to tumour initiation. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11284032     DOI: 10.1002/gcc.1114

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  Case report: renal cell carcinoma segregating with a t(2;3)(q37.3;q13.2) chromosomal translocation in an Ashkenazi Jewish family.

Authors:  L McKay; M Frydenberg; L Lipton; F Norris; I Winship
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

2.  Characterization of a 3;6 translocation associated with renal cell carcinoma.

Authors:  Rebecca E Foster; Mahera Abdulrahman; Mark R Morris; Elena Prigmore; Susan Gribble; Beeling Ng; Dean Gentle; Steven Ready; Phil M T Weston; Michael S Wiesener; Takeshi Kishida; Masahiro Yao; Val Davison; Jose Luis Barbero; Carol Chu; Nigel P Carter; Farida Latif; Eamonn R Maher
Journal:  Genes Chromosomes Cancer       Date:  2007-04       Impact factor: 5.006

Review 3.  Hereditary kidney cancer syndromes.

Authors:  Naomi B Haas; Katherine L Nathanson
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

Review 4.  Hereditary kidney cancer: unique opportunity for disease-based therapy.

Authors:  W Marston Linehan; Peter A Pinto; Gennady Bratslavsky; Elizabeth Pfaffenroth; Maria Merino; Cathy D Vocke; Jorge R Toro; Donald Bottaro; Len Neckers; Laura S Schmidt; Ramaprasad Srinivasan
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

5.  Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics.

Authors:  W Marston Linehan
Journal:  Genome Res       Date:  2012-10-04       Impact factor: 9.043

Review 6.  Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Authors:  Ning Yi Yap; Retnagowri Rajandram; Keng Lim Ng; Jayalakshmi Pailoor; Ahmad Fadzli; Glenda Carolyn Gobe
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

Review 7.  Expectant management and live birth outcomes for male balanced-translocation carriers: Two case reports and a literature review.

Authors:  Haitao Fan; Xiuyan Wang; Xiao Yang; Hongshu Zheng; Shuqiang Feng
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

Review 8.  Characterization of renal cell carcinoma-associated constitutional chromosome abnormalities by genome sequencing.

Authors:  Philip S Smith; James Whitworth; Hannah West; Jacqueline Cook; Carol Gardiner; Derek H K Lim; Patrick J Morrison; R Gordon Hislop; Emily Murray; Marc Tischkowitz; Anne Y Warren; Emma R Woodward; Eamonn R Maher
Journal:  Genes Chromosomes Cancer       Date:  2020-02-05       Impact factor: 5.006

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.